SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs strong quarterly results and raised outlook have been overshadowed by a post-earnings selloff, as traders focus on slower contract-booking growth and the stocks premium valuation. Bulls point to strong commercial AI demand and revenue growth, while bears question whether bookings can sustain the growth expectations priced into the shares.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys quarterly results sparked a sharp selloff as traders focused on revenue and GMV misses and moderating growth, despite stronger profit and cash flow; many see the reaction as excessive and point to a rebound, while bears argue the stocks high valuation leaves little room for disappointment.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A record quarterly report and raised fiscal-year outlook, supported by strong bookings and demand for AI-chip testing systems, drove AEHRs sharp rebound. Traders welcomed the results and see further AI-related growth potential, while skeptics question the valuation and whether the move can hold.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigals Q3 results, including strong Rezdiffra growth and its first profitable quarter, are driving attention. Bulls emphasize the launch momentum and MASH market opportunity, while skeptics point to spending and uncertainty around future clinical-outcomes data, debating why the stock faded despite the results.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiservs rally follows a Q3 earnings and revenue beat, a doubled cost-savings target and a planned share buyback, offering relief after a prolonged selloff. Traders are debating whether the results and new management mark a genuine turnaround or merely a bounce, while some attribute the move to short covering.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the following business segments: Cannabis and Plant Propagation. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Organigrams agreement to acquire Aurora, topping Curaleafs competing bid, has driven the sharp rally. Traders are debating whether Curaleaf could counter with a higher offer and whether the deal limits further upside; reactions range from welcoming the acquisition to calling for better terms.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Attention centers on Compass Pathways progress toward completing the FDA application for COMP360, its treatment-resistant depression therapy, and the prospect of an accelerated review and commercial launch in 2027. Traders are hopeful the regulatory milestone will lift the shares, while debating delays, launch execution and competition from Usonas psilocybin application for major depressive disorder.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP is drawing attention as part of the volatile rare-earth and critical-minerals trade, with traders weighing U.S.China supply tensions against the strategic case for domestic production. Some cite MPs magnet deliveries and expansion plans as support, while others focus on the sector-wide selloff and execution risks.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDBs CEO abruptly left for Meta ahead of Investor Day, sparking a sharp selloff and volatile trading. Reaffirmed guidance and former CEO Dev Ittycherias return as interim leader have encouraged dip-buying, while others remain concerned about succession uncertainty and the companys valuation.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins Q3 resultswith stronger operating profitability, expanding margins and record customer reachalongside a new share-repurchase program are driving attention. Bulls welcome the growth and buyback, while skeptics point to weak same-store sales and argue that OTC trading and uncertainty around a relisting are keeping the shares range-bound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf’s Rival Bid – ACB Stock Surges To Over 10-Month Highs

Organigrams agreement to acquire Aurora has displaced Curaleafs rival bid, prompting debate over whether Curaleaf will keep pursuing Aurora or move on to other acquisition opportunities. Some traders view losing the bid as avoiding a costly deal, while others speculate the takeover contest could continue.

Equity

Organigram is set to acquire Aurora for C$7.80 per share, a 32.4% premium to the stock’s closing price on Monday.


Should You Buy Curaleaf Stock Amid Its Hostile Bid for Aurora?

CURLF's hostile Aurora bid adds uncertainty as revenues recover, but margin pressure, rising costs and intense competition keep investors cautious.

Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?

Jazz Pharmaceuticals offers a differentiated medical cannabis play, with Epidiolex sales growth and a diversified portfolio offset by pipeline setbacks and earnings pressures.

TSNDF Stock Rises 6.5% in a Month: Time to Buy, Hold or Sell?

TerrAscend's improving revenues, margins and cash flow support its recovery, while debt, competition and regulatory uncertainty remain key concerns.

TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?

Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.

Are Medical Stocks Lagging  Cronos Group (CRON) This Year?

Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.

Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?

Cresco's 10% monthly rally reflects stronger revenues, organic growth and margins, but competition and normalization risks cloud the outlook.

Wall Street Analysts Predict a 43.69% Upside in Curaleaf Holdings, Inc. (CURLF): Here's  What You Should Know

The mean of analysts' price targets for Curaleaf Holdings, Inc. (CURLF) points to a 43.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?

Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.

Curaleaf Rejects Aurora Defense, Reiterates $4 Premium Offer  

In a statement on Monday, Curaleaf rejected Aurora’s assertions of inaccuracies in its unsolicited bid and accused the Canadian firm of using selective metrics to deflect from years of underperformance.


Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Aurora shareholders are expected to own roughly 35% of the combined company’s equity on a fully diluted basis.</li><li>The transaction is expected to be completed by January 2027.</li><li>Organigram edged out Curaleaf’s bid, which was revised to $5 per share last month.</li></ul>Shares of Aurora Cannabis (ACB) surged more than 20% on Tuesday, to their highest levels since December 2025, after Toronto-based Organigram Global (OGI) agreed to acquire the company for C$561 million ($400 million), potentially bringing an end to a prolonged takeover battle involving Curaleaf Holdings (CURLF).At the time of writing, CURLF shares were up around 13%, while OGI stock edged 1.3% lower.<h2 class="st-heading-2">Organigram Outbids Curaleaf</h2>Under the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20261103746636/en/Organigram-to-Acquire-Aurora-and-Establish-a-Global-Cannabis-Leader">agreement</a>, Organigram will acquire Aurora for C$7.80 per share, a 32.4% premium to the stock’s closing price on Monday. It also represents a 93% premium to Aurora’s unaffected share price on August 10, the last full trading day before Curaleaf’s first bid, according to&nbsp; Organigram.Curaleaf initially <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/curaleaf-launches-take-over-bid-to-acquire-aurora-cannabis-invites-aurora-shareholders-to-tender-to-the-bid-302854033.html">launched</a> a takeover bid in August, offering $4 per Aurora share. In October, Curaleaf <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/curaleaf-enhances-offer-to-acquire-aurora-cannabis-302898362.html">raised</a> its offer to an implied $5 per share after Aurora rejected its initial proposal.However, Aurora’s board again rejected the revised bid, arguing that it undervalued the company’s business.<h2 class="st-heading-2">Deal Expected To Close In January 2027</h2>Organigram’s bid&nbsp;received unanimous approval from both companies’ boards, with the deal expected to close in January 2027. Aurora shareholders are expected to own roughly 35% of the combined company’s equity on a fully diluted basis.The combined company will operate five production and distribution facilities, with expected cost savings exceeding C$50 million. British American Tobacco (BATS), a strategic investor in Organigram, will provide C$187.5 million in financing to support the acquisition.The merger would combine Organigram’s recreational cannabis operations with Aurora’s international medical cannabis business, expanding their presence across Canada, Europe and Australia.<h2 class="st-heading-2">Retail Sees 4X Growth Potential In <a class="mention" data-mention="$ACB" data-symbol-id="ACB" href="https://stocktwits.com/symbol/ACB" target="_blank">ACB Stock</a></h2>Retail sentiment for ACB on Stocktwits turned ‘bullish’ from ‘neutral’ over the past 24 hours, amid a 433% surge in message volumes. Sentiment flipped to ‘bullish’ from ‘bearish’ for CURLF<img src="https://news.stocktwits-cdn.com/ACB_e1d803f011.png" alt="ACB.png"><img src="https://news.stocktwits-cdn.com/CURLF_e18ed9217c.png" alt="CURLF.png">One user highlighted BATS’ involvement and expects ACB to climb above $20. It is currently trading at $5.<stembedurl>https://stocktwits.com/Mikmee/message/668022941</stembedurl>ACB shares have jumped about 17% so far in 2026.Also read:<a href="https://stocktwits.com/news-articles/markets/equity/tesla-s-china-made-ev-sales-rise-for-12th-straight-month-european-recovery-adds-to-momentum/cNGXECcR95t">&nbsp;Tesla’s China-Made EV Sales Rise For 12th Straight Month – European Recovery Adds To Momentum</a>For updates and corrections, email newsroom[at]stocktwits[dot]com(Exchange rate: CAD1 = $0.7)

Kraken Robotics on Tuesday announced that it has entered into an agreement to acquire Covelya Group Limited.(Image Courtesy: Getty Images)

Organigram is set to acquire Aurora for C$7.80 per share, a 32.4% premium to the stock’s closing price on Monday.

OrganiGram Holdings Inc.

Roundhill Cannabis ETF

Republicans keep both chambers

Republicans keep the House, lose the Senate

Republicans keep the Senate, lose the House

Democrats win both chambers

Stocktwits

Stocktwits Polls

Investors are speculating on the likelihood of a strategic acquisition contest following recent market moves among industry players.

Current Price	$9.75
Prev Close	$9.16
Open	$9.25
Dividend Yield	N/A
50-Day Moving Average	$9.55
Beta	1.12
Avg. Volume	170,650.09
PE Ratio	-51.20

52-Week High	$15.15
52-Week Low	$5.40
Market Capitalization	$2.43B
EPS (Annual)	-$1.08
Price to Book	2.80
Revenue Per Employee	$228,328.23

Feed

News

Sentiment

Earnings

Fundamentals

Info

CURLF Fundamentals